Alaye siwaju sii ― Yoruba

Confluent and reticulated papillomatosis (CRP), ti a tun pe ni iṣọn‑aisan Gougerot‑Carteaud, jẹ abajade ti idagbasoke sẹẹli awọ ara ajeji. O ṣe afihan gẹ́gẹ́ bí àwọn àyè dudu tí kò ní irora tí ó lè dápọ̀ sí àbùlẹ̀ ńlá, tí wọ́n sábà máa hàn lórí àyà òkè àti ọ̀run àwọn ọdọ àti àwọn agbalagba. Aṣàyàn ìtọ̀jú àkọ́kọ́ ni minocycline.
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.

CRP maa n farahan gẹ́gẹ́ bí àwọ̀ dudu àti àbùlù tí kò ní ààmì àìlera lórí awọ̀ ara ní agbègbè ọ̀run, àwọn àpá, àyà òkè, àti ẹ̀hìn òkè. Nígbà míì, ó lè tan sórí iwájú àti isalẹ sí àgbègbè míì. Ẹ̀rọ̀ọ̀rọ̀ bíi minocycline ti di yíyan ìtọ́jú tó dára jùlọ.
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.